A breakthrough in the quest to find a blood test for Alzheimer's will help doctors and patients "manage the disease", one of the researchers has said.
Professor Howard Federoff explained:
Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder.
The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention.
Biomarkers such as ours that define this asymptomatic period are critical for successful development and application of these therapeutics.
We consider our results a major step toward the commercialisation of a preclinical disease biomarker test.
More top news
YouTube superstar Alfie Deyes got a sense of how far he has come when thousands of fans descended on his latest book signing in London.
The last blog from woman about her final days after she was diagnosed with cancer - and the things she valued in life - has gone viral.
Ed Miliband would rather discuss working families and the NHS, but the question of English 'home rule' looms large over Labour's conference.